ForGrowth III PA B.V. 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 09:46 am Sale | 2025-10-16 | 13G | ASTRIA THERAPEUTICS INC ATXS | ForGrowth III PA B.V. | 0 0.000% | -3,822,537 (Position Closed) | Filing |
| 2025-05-15 08:45 am Purchase | 2025-03-31 | 13G | ASTRIA THERAPEUTICS INC ATXS | ForGrowth III PA B.V. | 3,822,537 6.800% | 950,000 (+33.07%) | Filing |
| 2025-01-07 07:45 am Purchase | 2024-12-30 | 13G | ASTRIA THERAPEUTICS INC ATXS | ForGrowth III PA B.V. | 2,872,537 5.100% | 2,872,537 (New Position) | Filing |